3D Tomo Receives FDA Approval: Inline with our prior assumptions, continue to model contribution in Q3 On March 27th iCAD (ICAD) announced that PowerLook Tomo Detection, their 3D tomosynthesis ...
NASHUA, N.H., April 26, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback